Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-03

Clinical Trial Update: Improving the Prognosis for Cerebral Hemorrhage A Study of Clinical, Biological, and Imaging Markers

View source ↗

Summary

This clinical trial aims to improve prognosis after intracerebral hemorrhage by studying clinical, biological, and imaging markers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Tours | Conditions: Intracerebral Hemorrhage (ICH) | Status: NOT_YET_RECRUITING